Wed, August 10, 2022

Rick Bienkowski Maintained (BEAM) at Buy with Decreased Target to $113 on, Aug 10th, 2022

Rick Bienkowski of SVB Leerink, Maintained "Beam Therapeutics Inc." (BEAM) at Buy with Decreased Target from $118 to $113 on, Aug 10th, 2022.

Rick has made no other calls on BEAM in the last 4 months.



There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, all agree with Rick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kostas Biliouris of "BMO Capital" Initiated at Hold and Held Target at $41 on, Friday, June 17th, 2022
  • Richard Law of "Credit Suisse" Initiated at Hold and Held Target at $62 on, Thursday, April 28th, 2022